VIM and invasive breast carcinoma: A strong association was observed with histological grade: none of the Grade I tumors [0 of 19 cases (0.0%)] were positive, whereas positivity was present in 7 of 38 Grade II tumors (18.42%) and 10 of 13 Grade III tumors (76.92%).<h4>Conclusions</h4>Vimentin expression in invasive breast carcinoma is associated with adverse pathological features, particularly larger tumor size, higher nodal burden, and most strongly, higher histological grade.